5648-88-4

Usage

Uses

Used in Research Laboratories:
3-Cyclopropylpropan-1-amine Hydrochloride is used as a reagent for facilitating various chemical reactions and synthetic procedures, contributing to the advancement of scientific research and development.
Used in Biochemistry and Drug Discovery:
3-Cyclopropylpropan-1-amine Hydrochloride is used as a modifying agent for proteins and enzymes, aiding in the discovery and development of new drugs and therapeutic agents.
Used in Pharmaceutical Development:
3-Cyclopropylpropan-1-amine Hydrochloride is used as a potential component in the development of new drugs targeting neurological and psychiatric disorders, due to its ability to interact with biological systems at a molecular level.
Used in Organic Chemistry:
3-Cyclopropylpropan-1-amine Hydrochloride is used as a building block in the synthesis of other organic compounds, playing a crucial role in the creation of complex organic molecules and materials.

Upstream product

• 5266-72-8 3-cyclopropylpropanenitrile 
• 63064-31-3 4-methylphenyl sulfonic acid (2-cyclopropylethyl) ester 
• 2566-44-1 1-cyclopropylethanol 

Downstream Products

• 881384-25-4 5-[4-(2-Trifluoromethyl benzoyl)piperazin-1-yl][1,3,4]oxadiazole-2-carboxylic acid (3-cyclopropyl propyl) amide 
• 881384-12-9 5-[4-(2-Trifluoromethyl-benzoyl)-piperazin-1-yl]-[1,3,4]thiadiazole-2-carboxylic acid (3-cyclopropyl-propyl)-amide 
• 840490-94-0 6-[4-(2-trifluoromethylbenzoyl)piperazin-1-yl]pyridazine-3-carboxylic acid (3-cyclopropylpropyl)amide 
• 881382-16-7 N-(3-Cyclopropylpropyl)-2-[4-(5-fluoro-2-trifluoromethylbenzoyl)piperazin-1-yl]isonicotinamide 

Relevant academic research and scientific papers

SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted imidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

Piperazine derivatives and their use as therapeutic agents

Compounds for treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the compounds are of formula (I): where x y, W, V, R 2 , R 3 , R 4 , R 5 , R 6 , R 6a , R 7 , R 7a , R 8 , R 8a , R 9 and R 9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.

Pyridine Derivatives For Inhibiting Human Stearoyl-Coa-Desaturase

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I) where x, y, G, J, K, L, M, W, V, R2, R3, R4, R5, R5a,

BICYCLIC HETEROCYCLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF STEAROYL-COA-DESATURASE (SCD)

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise, for example, administering to a mammal in need thereof a compound of formula (I): where x, y, J, K, L, M, W, V, R2